Kim Forest Enterprise Co., Ltd. (TPE:6645)

Market Cap	1.05B -17.6%
Revenue (ttm)	531.58M +12.4%
Net Income	-163.62M
EPS	-2.77
Shares Out	60.62M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	59,821
Average Volume	32,350
Open	17.60
Previous Close	17.50
Day's Range	17.35 - 17.75
52-Week Range	16.20 - 26.45
Beta	0.04
RSI	41.84
Earnings Date	Mar 11, 2026

About Kim Forest Enterprise

Kim Forest Enterprise Co., Ltd. provides various genetic and medical testing services in China and the United States. The company offers genetic testing, drug report, and monitoring tools for cancer patients; and GoL Life that provides a non-invasive genome-wide health assessment for healthy persons. It also provides bioinformatics service items; prenatal test kits; and genetically modified models. In addition, the company offers SARS-CoV-2 detection kits. Further, it engages in the wholesale of medical instruments and consumables; and provisio...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2004
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6645

Financial Performance

In 2024, Kim Forest Enterprise's revenue was 501.53 million, an increase of 20.85% compared to the previous year's 415.01 million. Losses were -159.88 million, 56.0% more than in 2023.